Move log
Jump to navigation
Jump to search
Below is a list of all page moves.
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 17:56, 9 June 2024 Jwarner talk contribs moved page Imetelstat (GRN-163L) to Imetelstat (Rytelo) (FDA approval)
- 18:51, 17 May 2024 Jwarner talk contribs moved page Tarlatamab (AMG-757) to Tarlatamab (Imdelltra) (FDA approval)
- 10:38, 14 April 2024 Jwarner talk contribs moved page Iptacopan (LNP-023) to Iptacopan (Fabhalta) (FDA approval)
- 18:21, 10 April 2024 PeterYang talk contribs moved page File:20211027 HemOnc SOP QA.pdf to File:HemOnc SOP QA.pdf (rename)
- 12:35, 2 February 2024 Jwarner talk contribs moved page Momelotinib (CYT-387) to Momelotinib (Ojjaara) (FDA approval)
- 21:49, 23 January 2024 Jwarner talk contribs moved page Ovarian cancer, BRCA-mutated to Ovarian cancer, HRD-positive (Renaming to make the page more generic for HRD rather than just BRCA)
- 16:06, 20 December 2023 Warner-admin talk contribs moved page Allogeneic HSCT conditioning regimens to Allogeneic HSCT without leaving a redirect
- 16:05, 20 December 2023 Warner-admin talk contribs moved page Autologous HSCT conditioning regimens to Autologous HSCT without leaving a redirect
- 23:46, 27 November 2023 Jwarner talk contribs moved page Nirogacestat (PF-03084014) to Nirogacestat (Ogsiveo) (FDA approval)
- 17:31, 26 November 2023 Jwarner talk contribs moved page Category:Local therapies to Category:Locally delivered therapies
- 15:10, 26 November 2023 Jwarner talk contribs moved page Chimeric antigen receptor T cells (CAR-T) to Cellular therapy conditioning regimens
- 15:09, 26 November 2023 Jwarner talk contribs moved page Stem cell mobilization to Stem cell mobilization regimens
- 15:07, 26 November 2023 Jwarner talk contribs moved page Autologous HSCT to Autologous HSCT conditioning regimens over redirect
- 15:05, 26 November 2023 Jwarner talk contribs moved page Allogeneic HSCT to Allogeneic HSCT conditioning regimens over redirect
- 13:55, 26 November 2023 Jwarner talk contribs moved page Niraparib and Abiraterone (Akeega) to Niraparib and abiraterone (Akeega)
- 03:09, 26 November 2023 Jwarner talk contribs moved page Mycostatin (Nystatin) to Nystatin (Mycostatin) (error in brand naming)
- 14:14, 18 November 2023 Jwarner talk contribs moved page Toripalimab (Loqtorz) to Toripalimab (Loqtorzi) (Brand name not spelled right)
- 14:26, 17 November 2023 Jwarner talk contribs moved page Anlotinib (AL-3818) to Anlotinib (Fukewei) (brand name)
- 12:32, 17 November 2023 Jwarner talk contribs moved page Capivasertib (AZD-5363) to Capivasertib (Truqap) (FDA approval)
- 17:12, 7 November 2023 Jwarner talk contribs moved page Bacillus Calmette-Guérin (BCG) to BCG vaccine (INN)
- 00:14, 4 November 2023 Jwarner talk contribs moved page Fruquintinib (HMPL-013) to Fruquintinib (Elunate) (brand name)
- 15:55, 30 October 2023 Warner-admin talk contribs moved page Toripalimab (Tuoyi) to Toripalimab (Loqtorz) (Text replacement - "Toripalimab (Tuoyi)" to "Toripalimab (Loqtorz)")
- 00:19, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-EGFR/HGFR bispecific antibodies to Category:Anti-EGFR-HGFR bispecific antibodies without leaving a redirect (Text replacement - "/HGFR bispecific" to "-HGFR bispecific")
- 00:19, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-BCMA/CD3 bispecific antibodies to Category:Anti-BCMA-CD3 bispecific antibodies without leaving a redirect (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")
- 00:18, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-CD33/CD3 bispecific antibodies to Category:Anti-CD33-CD3 bispecific antibodies without leaving a redirect (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")
- 00:18, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-Factor IXa/Factor Xa bispecific antibodies to Category:Anti-Factor IXa-Factor Xa bispecific antibodies without leaving a redirect (Text replacement - "/Factor Xa bi" to "-Factor Xa bi")
- 00:17, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-EpCAM/CD3 bispecific antibodies to Category:Anti-EpCAM-CD3 bispecific antibodies without leaving a redirect (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")
- 00:15, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-CD20/CD3 bispecific antibodies to Category:Anti-CD20-CD3 bispecific antibodies without leaving a redirect (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")
- 00:15, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-CD19/CD3 bispecific antibodies to Category:Anti-CD19-CD3 bispecific antibodies without leaving a redirect (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")
- 00:15, 18 October 2023 Warner-admin talk contribs moved page Melphalan for Injection/Hepatic Delivery System (Hepzato Kit) to Melphalan for Injection-Hepatic Delivery System (Hepzato Kit) without leaving a redirect (Breaking special character)
- 00:13, 18 October 2023 Warner-admin talk contribs moved page Category:Anti-GPRC5D/CD3 bispecific antibodies to Category:Anti-GPRC5D-CD3 bispecific antibodies without leaving a redirect (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")
- 20:50, 3 October 2023 Jwarner talk contribs moved page Category:Anti-GPRC5D bispecific T-cell engager antibodies to Category:Anti-GPRC5D/CD3 bispecific antibodies
- 20:47, 3 October 2023 Jwarner talk contribs moved page Category:Anti-EpCAM bispecific T-cell engager antibodies to Category:Anti-EpCAM/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD33 bispecific T-cell engager antibodies to Category:Anti-CD33/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD19 bispecific T-cell engager antibodies to Category:Anti-CD19/CD3 bispecific antibodies
- 20:43, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD20 bispecific T-cell engager antibodies to Category:Anti-CD20/CD3 bispecific antibodies
- 20:40, 3 October 2023 Jwarner talk contribs moved page Category:Anti-BCMA bispecific T-cell engager antibodies to Category:Anti-BCMA/CD3 bispecific antibodies
- 15:22, 29 September 2023 Jwarner talk contribs moved page Folinic acid (Leucovorin) to Leucovorin (Folinic acid) (Alignment with INN)
- 13:34, 23 September 2023 Warner-admin talk contribs moved page Category:Pyrimidine analogues to Category:Pyrimidine analogs (Text replacement - "analogues" to "analogs")
- 13:34, 23 September 2023 Warner-admin talk contribs moved page Category:Purine analogues to Category:Purine analogs (Text replacement - "analogues" to "analogs")
- 13:29, 23 September 2023 Warner-admin talk contribs moved page Category:Deoxycytidine analogues to Category:Deoxycytidine analogs (Text replacement - "analogues" to "analogs")
- 13:07, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-EpCAM BiTE antibodies to Category:Anti-EpCAM bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:06, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-CD20 BiTE antibodies to Category:Anti-CD20 bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:06, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-CD3 BiTE antibodies to Category:Anti-CD3 bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:06, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-BCMA BiTE antibodies to Category:Anti-BCMA bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:05, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-CD33 BiTE antibodies to Category:Anti-CD33 bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:05, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-GPRC5D BiTE antibodies to Category:Anti-GPRC5D bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:04, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-CD19 BiTE antibodies to Category:Anti-CD19 bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:03, 23 September 2023 Warner-admin talk contribs moved page Category:BiTE antibodies to Category:Bispecific T-cell engager antibodies without leaving a redirect
- 23:38, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) medications to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications